Oral Carnitine in Heart Failure Patients

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Heart FailureCarnitine Deficiency

Interventions

DRUG

Levocarnitine

Oral L-carnitine, 2970mg daily (950mg, to be taken 3 times a day) for 3 months.

Trial Locations (1)

London Health Sciences Centre, London

All Listed Sponsors

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER